In this study of hormone receptor-positive BC (HRBC), we explored the prognostic value of IHC, performed on full-face surgical excision slides, by combining DIA data from multiple IHC biomarkers, along with their intratumoral heterogeneity indicators and tissue immune response properties, in the context of conventional clinicopathologic variables. This evidence concerns the gene NR4A1 and breast cancer.